Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

NCT01715805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1022

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Cariprazine
DRUG: Placebo
DRUG: Antidepressant Therapy (ADT)

Sponsor

Forest Laboratories

Collaborators

[object Object]